EGFR and colorectal carcinoma: At present, a variety of targeted drugs such as epidermal growth factor receptor (EGFR) inhibitors (cetuximab, panitumumab) and vascular endothelial growth factor (VEGF) inhibitors (bevacizumab) have been used in the treatment of CRC, but the current targeted drug therapy still has problems of resistance and side effects.